文献速递胰腺与胆道疾病

改良胰腺炎活动评分系统在急性胰腺炎中显示不同轨迹:一项国际研究

The Modified Pancreatitis Activity Scoring System Shows Distinct Trajectories in Acute Pancreatitis: An International Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-09-17

该研究基于APPRENTICE前瞻性队列(2015-2018年,4大洲22中心,1393例急性胰腺炎患者),评估PASS性能并探究改良PASS(mPASS)的预测准确性及早期轨迹差异。结果显示轻症患者各时间点PASS最低(均P<.001),mPASS-1(去除吗啡等效剂量)预测重症AP的AUC为0.88(常规PASS为0.83),且不同严重度亚组轨迹斜率显著不同(均P<.001)。

要点

  • mPASS-1去除吗啡等效剂量,计算更简便且预测重症AP的AUC达0.88。
  • 轻症AP各时间点PASS均显著低于中重症(P<.001)。
  • mPASS-1在不同严重度亚组间产生显著不同的早期轨迹斜率(P<.001)。

核心结论

  • 去除吗啡等效剂量组分的mPASS-1模型更易计算,能准确预测重症急性胰腺炎,并保持严重度亚组间显著不同的早期轨迹。

研究设计与样本

  • 前瞻性队列研究,通过APPRENTICE联盟(2015-2018年)纳入4大洲22中心共1393例急性胰腺炎患者,中位年龄49岁,51%为男性。

主要发现

  • 队列含轻症950例(68.2%)、中度重症315例(22.6%)、重症128例(9.2%)。
  • 轻症患者在每个研究时间点PASS均最低(所有P<.001)。
  • 异常入组PASS亚组中,70%的PASS变异归因于吗啡等效剂量,66%患者来自美国中心。
  • mPASS-1预测重症AP的AUC为0.88,常规PASS为0.83。
  • mPASS-1在严重度亚组间产生斜率显著不同的轨迹(所有P<.001)。

关键数值与推荐

  • mPASS-1预测重症AP的AUC为0.88(常规PASS为0.83)。
  • 严重度分组依据修订版亚特兰大分类。
  • mPASS-1轨迹在严重度亚组间斜率差异均有统计学意义(所有P<.001)。

临床怎么用

  • 可考虑采用去除吗啡等效剂量的mPASS-1评估急性胰腺炎严重度及早期轨迹,计算更简便且预测准确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The aims of this study were to: (1) assess the performance of the Pancreatitis Activity Scoring System (PASS) in a large intercontinental cohort of patients with acute pancreatitis (AP); and (2) investigate whether a modified PASS (mPASS) yields a similar predictive accuracy and produces distinct early trajectories between severity subgroups. METHODS: Data was prospectively collected through the Acute Pancreatitis Patient Registry to Examine Novel Therapies In Clinical Experience (APPRENTICE) consortium (2015-2018) involving 22 centers from 4 continents. AP severity was categorized per the revised Atlanta classification. PASS trajectories were compared between the three severity groups using the generalized estimating equations model. Four mPASS models were generated by modifying the morphine equivalent dose (MED), and their trajectories were compared. RESULTS: A total of 1393 subjects were enrolled (median age, 49 years; 51% males). The study cohort included 950 mild (68.2%), 315 (22.6%) moderately severe, and 128 (9.2%) severe AP. Mild cases had the lowest PASS at each study time point (all P < .001). A subset of patients with outlier admission PASS values was identified. In the outlier group, 70% of the PASS variation was attributed to the MED, and 66% of these patients were from the United States centers. Among the 4 modified models, the mPASS-1 (excluding MED from PASS) demonstrated high performance in predicting severe AP with an area under the receiver operating characteristic curve of 0.88 (vs area under the receiver operating characteristic of 0.83 in conventional PASS) and produced distinct trajectories with distinct slopes between severity subgroups (all P < .001). CONCLUSION: We propose a modified model by removing the MED component, which is easier to calculate, predicts accurately severe AP, and maintains significantly distinct early trajectories.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Paragomi P, Hinton A, Pothoulakis I, et al. The Modified Pancreatitis Activity Scoring System Shows Distinct Trajectories in Acute Pancreatitis: An International Study. Clin Gastroenterol Hepatol. 2021. PMID: 34543736. doi:10.1016/j.cgh.2021.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。